RxDoctor Payments Data

Christopher Ho, DO

Internal Medicine · Glenview, ILNPI 1053765040

Payments from drug & device makers

$385in general payments, 2019–2025

Across 20 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$62
  • Sanofi Pasteur Inc.$45
  • Amgen$45
  • GSK$36
  • AbbVie$28
  • AstraZeneca$26
  • plus $144 from 7 others

What the payments were for

  • Food & beverage$385100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$385 in reported general payments places this provider in the 65th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$259,504
Medicare patients
524
Services billed
2,911

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban154$124,490
OzempicSemaglutide68$77,336
TrulicityDulaglutide27$31,804
MyrbetriqMirabegron17$11,309
JardianceEmpagliflozin12$7,891
Atorvastatin Calcium674$6,791
DuleraMometasone/Formoterol18$6,772
Levothyroxine Sodium402$5,140
Metoprolol Succinate216$4,481
Rosuvastatin Calcium236$4,016
Amlodipine Besylate424$3,746
Donepezil Hcl91$3,194
Olmesartan Medoxomil98$3,029
SynthroidLevothyroxine Sodium35$3,016
Mirtazapine116$2,978

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$16$11,30917 claims
MerckDulera$16$6,77218 claims
AbbVieSynthroid$28$3,01635 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Glenview

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →